TFS Capital’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-17,125
Closed -$356K 643
2017
Q1
$356K Buy
+17,125
New +$356K 0.12% 329